NCT02465060
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) screening 2 active_not_recruiting NCT00217633
Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer No drug interventions treatment 2 completed NCT06157151
PRGN-2009 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer treatment 2 recruiting NCT01267253
Brivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical Cancer treatment 2 completed NCT01693783
Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer treatment 2 completed NCT05310383
Tislelizumab and Radiotherapy for Recurrent Cervical Cancer treatment 2 unknown_status NCT02257528
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer treatment 2 active_not_recruiting NCT00041093
Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer treatment 2 completed NCT03439085
DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers treatment 2 terminated NCT01281852
Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer treatment 1 completed NCT00309959
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer treatment 2 completed NCT03170570
the Re-irradiation of Recurrent Cervical Cancer by IMRT No drug interventions treatment Not Available unknown_status NCT03968406
Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers treatment 1 recruiting NCT02646319
Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations treatment 0 completed NCT05290935
Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy: Multi-Center Trial treatment 2 unknown_status NCT04574635
Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer No drug interventions Not Available Not Available recruiting NCT01098630
Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer No drug interventions Not Available Not Available completed NCT04188860
Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy treatment 2 completed NCT01266460
Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer treatment 2 completed NCT01026792
Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgery treatment 2 completed NCT04664244
Combination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous Carcinoma treatment 2 unknown_status NCT03987555
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients No drug interventions Not Available Not Available recruiting NCT03345784
Testing AZD1775 inC Combination With Radiotherapy and Chemotherapy in Cervical, Upper Vaginal and Uterine Cancers treatment 1 terminated NCT03816553
SHR-1210 in Combination With Apatinib in Patients With Metastatic, Persistent, or Recurrent Cervical Cancer treatment 2 completed NCT00064077
Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix treatment 3 completed NCT01266447
Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer treatment 2 completed NCT04188847
First-line Chemotherapy for Recurrent Cervical Cancer treatment 2 completed NCT05310305
PD-1 Antibody and Radiotherapy for Recurrent Cervical Cancer No drug interventions Not Available Not Available unknown_status NCT01992861
MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer No drug interventions Not Available Not Available terminated NCT02578888
Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malignancies No drug interventions supportive_care Not Available completed NCT04635956
Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas No drug interventions treatment 2 unknown_status NCT03452332
Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers treatment 1 completed NCT03508570
Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis treatment 1 active_not_recruiting NCT00039442
Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer treatment 2 completed NCT00897442
Collecting Tumor Samples From Patients With Gynecological Tumors No drug interventions Not Available Not Available completed NCT06238635
Dostarlimab and Cobolimab in Advanced Cervical Cancer treatment 2 recruiting NCT00057863
Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer treatment 2 completed NCT03277482
Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer treatment 1 terminated NCT05310331
Donafenib for Recurrent Cervical Cancer treatment 2 unknown_status NCT00499031
Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer treatment 2 completed NCT00803062
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer treatment 3 completed NCT02921269
Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer treatment 2 completed